Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Meyer

Showing results (321-330 of 406) with videos related to

Pageof 41
Sort By:
Arthritis and Rheumatism|August 1, 2009
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosisP Dieudé, M Guedj, J Wipff, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian populationP Dieudé, M Guedj, J Wipff, et al.
The Review of Scientific Instruments|December 3, 2016
Development of visible spectroscopy diagnostics for W sources assessment in WESTO Meyer, O M Jones, J C Giacalone, et al.
Clinical and Experimental Rheumatology|June 8, 2002
Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy. A pilot surveyJ M Berthelot, H J Bernelot-Moens, M Klarlund, et al.
Environmental Health Perspectives|August 1, 1996
Male reproductive health and environmental xenoestrogensJ Toppari, J C Larsen, P Christiansen, et al.
Arthritis and Rheumatism|October 31, 2009
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4P Dieudé, J Wipff, M Guedj, et al.
Annals of the Rheumatic Diseases|June 7, 2015
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registryJ H Salmon, J E Gottenberg, P Ravaud, et al.
Annals of the Rheumatic Diseases|December 15, 2010
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisP Dieudé, M Guedj, J Wipff, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's SyndromeC Vitali, S Bombardieri, H M Moutsopoulos, et al.
Arthritis and Rheumatism|September 8, 2011
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotypeP Dieudé, M Bouaziz, M Guedj, et al.
Pageof 41

Showing results (321-330 of 406) with videos related to

Sort By:
Pageof 41
Arthritis and Rheumatism|August 1, 2009
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosisP Dieudé, M Guedj, J Wipff, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian populationP Dieudé, M Guedj, J Wipff, et al.
The Review of Scientific Instruments|December 3, 2016
Development of visible spectroscopy diagnostics for W sources assessment in WESTO Meyer, O M Jones, J C Giacalone, et al.
Clinical and Experimental Rheumatology|June 8, 2002
Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy. A pilot surveyJ M Berthelot, H J Bernelot-Moens, M Klarlund, et al.
Environmental Health Perspectives|August 1, 1996
Male reproductive health and environmental xenoestrogensJ Toppari, J C Larsen, P Christiansen, et al.
Arthritis and Rheumatism|October 31, 2009
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4P Dieudé, J Wipff, M Guedj, et al.
Annals of the Rheumatic Diseases|June 7, 2015
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registryJ H Salmon, J E Gottenberg, P Ravaud, et al.
Annals of the Rheumatic Diseases|December 15, 2010
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisP Dieudé, M Guedj, J Wipff, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's SyndromeC Vitali, S Bombardieri, H M Moutsopoulos, et al.
Arthritis and Rheumatism|September 8, 2011
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotypeP Dieudé, M Bouaziz, M Guedj, et al.
Pageof 41